People are silhouetted at the Porsche annual meeting in Stuttgard, Germany, May 13, 2015. Volkswagen’s controlling Porsche and Piech families have pledged to maintain their engagement in Europe’s largest automaker despite last month’s dramatic leadership dispute. REUTERS/Ralph Orlowski/File Photo Acquire Licensing Rights BERLIN, Nov 13 (Reuters) – Porsche SE (PSHG_p.DE) said on Monday that net… Continue reading Porsche SE expects net liquidity at year-end in upper forecast range
Tag: M and A
SunExpress to Buy up to 90 Boeing 737 MAX Jets to Fuel Robust Growth
DUBAI, United Arab Emirates, Nov. 13, 2023 /PRNewswire/ — Boeing [NYSE: BA] and SunExpress, a joint venture of Turkish Airlines and Lufthansa, announced today the airline has again selected the 737 MAX to continue its robust growth. With a commitment to purchase up to 90 fuel-efficient single-aisle Boeing jets, announced at the Dubai Airshow, Türkiye’s… Continue reading SunExpress to Buy up to 90 Boeing 737 MAX Jets to Fuel Robust Growth
Pega Helps Shawbrook Cut Mortgage Processing Times in Half
Specialist UK savings and lending bank expands use of Pega to triple underwriter output and accelerate mortgage offers READING, UK, Nov. 13, 2023 /PRNewswire/ — Pegasystems Inc. (NASDAQ: PEGA), the low-code platform provider empowering the world’s leading enterprises to Build for Change® , today announced that Shawbrook, a UK-based specialist savings and lending bank, has deployed Pega… Continue reading Pega Helps Shawbrook Cut Mortgage Processing Times in Half
Medivir to present clinical data at ASCO-GI with fostrox + Lenvima in HCC and shares positive response from Type D meeting with FDA
STOCKHOLM, Nov. 13, 2023 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical data from the ongoing phase 1b/2a study of in fostroxacitabine bralpamide (fostrox) in combination with Lenvima® (lenvatinib) in hepatocellular carcinoma (HCC), will be presented… Continue reading Medivir to present clinical data at ASCO-GI with fostrox + Lenvima in HCC and shares positive response from Type D meeting with FDA
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announce an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance[1] through a strategic €6.0 million (AU$9.6 million[2]) investment to develop new hybrid pharmaceutical-device products through the combination… Continue reading Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
Xinhua Silk Road: 2023 China (Zhejiang) Forum on China-Africa Economic and Trade Relations kicks off E. China’s Jinhua
BEIJING, Nov. 12, 2023 /PRNewswire/ — The opening ceremony of the 2023 China (Zhejiang) Forum on China-Africa Economic and Trade Relations and China-Africa Cultural Cooperation and Exchange Month kicked off on Wednesday in Jinhua City, east China’s Zhejiang Province. The forum, co-sponsored by the Chinese People’s Association for Friendship with Foreign Countries, the China Council… Continue reading Xinhua Silk Road: 2023 China (Zhejiang) Forum on China-Africa Economic and Trade Relations kicks off E. China’s Jinhua
Smart Grid Market size in China to grow by USD 13.96 billion from 2022 to 2027|Transition to smart grids drives the market – Technavio
NEW YORK, Nov. 13, 2023 /PRNewswire/ — The smart grid market in China is estimated to grow by USD 13.96 billion from 2022 to 2027, growing at a CAGR of 14.34%. Transition to smart grids is a major factor notably driving the market growth. A smart grid is generally an integrated network that combines all the power network… Continue reading Smart Grid Market size in China to grow by USD 13.96 billion from 2022 to 2027|Transition to smart grids drives the market – Technavio
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announce an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance[1] through a strategic €6.0 million (AU$9.6 million[2]) investment to develop new hybrid pharmaceutical-device products through the combination… Continue reading Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
Repurchase of Truecaller B shares in week 45, 2023
STOCKHOLM, Nov. 13, 2023 /PRNewswire/ — During 6 November 2023 and 10 November 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 1,300,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors. The share buybacks form part of the share buyback programme announced by Truecaller… Continue reading Repurchase of Truecaller B shares in week 45, 2023
Integris Composites Launches Customizable Ballistic Shields and Vests at Milipol Paris
Breakthrough survivability technology puts military and police users first PARIS, Nov. 13, 2023 /PRNewswire/ — Integris Composites, the global leader in armor protection for the world’s elite military and law-enforcement units, will display its new “make your own shield” concept and soft body armor vests at Milipol Paris 2023 Stand 5 F009, taking place Nov.… Continue reading Integris Composites Launches Customizable Ballistic Shields and Vests at Milipol Paris